NPI: 1013233741 · OTTUMWA, IA 52501 · General Acute Care Hospital · NPI assigned 04/20/2010
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 04/20/2010 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 32,027 | $1.84M |
| 2019 | 29,042 | $1.46M |
| 2020 | 27,885 | $1.24M |
| 2021 | 32,969 | $1.54M |
| 2022 | 36,702 | $1.70M |
| 2023 | 23,563 | $1.15M |
| 2024 | 10,509 | $652K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 14,208 | 12,921 | $2.91M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 18,648 | 17,177 | $2.71M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,770 | 4,236 | $1.51M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,990 | 4,451 | $576K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,025 | 942 | $417K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2,081 | 953 | $332K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3,745 | 2,481 | $232K |
| 97597 | 1,851 | 935 | $144K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,672 | 3,251 | $141K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,111 | 1,935 | $136K |
| 71045 | Radiologic examination, chest; single view | 2,452 | 2,122 | $129K |
| 71046 | Radiologic examination, chest; 2 views | 1,427 | 1,304 | $83K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 398 | 374 | $38K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,843 | 1,687 | $30K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 495 | 459 | $27K |
| 93458 | 15 | 12 | $25K | |
| 70450 | Computed tomography, head or brain; without contrast material | 163 | 143 | $21K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 25 | 25 | $20K |
| J3490 | Unclassified drugs | 5,593 | 3,037 | $15K |
| 29581 | 193 | 78 | $14K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 253 | 247 | $12K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 452 | 136 | $11K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,013 | 1,845 | $7K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 28 | 27 | $6K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 47 | 41 | $4K |
| 62323 | 14 | 12 | $4K | |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 412 | 341 | $4K |
| 59025 | Fetal non-stress test | 22 | 13 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7,434 | 6,232 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 37 | 37 | $2K |
| A0425 | Ground mileage, per statute mile | 1,297 | 1,000 | $2K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 77 | 24 | $2K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 32 | 13 | $1K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 13 | 12 | $1K |
| 80053 | Comprehensive metabolic panel | 20,915 | 18,342 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 22,611 | 19,584 | $1K |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 138 | 108 | $695.63 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 12 | 12 | $609.46 |
| 36415 | Collection of venous blood by venipuncture | 11,448 | 9,628 | $597.18 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,356 | 1,489 | $386.26 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,054 | 1,891 | $303.23 |
| 84484 | 6,073 | 4,616 | $275.67 | |
| 87999 | 2,001 | 1,780 | $251.00 | |
| J2704 | Injection, propofol, 10 mg | 3,662 | 3,216 | $177.69 |
| 83690 | 1,896 | 1,676 | $154.75 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,381 | 1,256 | $154.09 |
| 80048 | Basic metabolic panel (calcium, ionized) | 340 | 294 | $153.93 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 66 | 56 | $92.00 |
| 81001 | 5,427 | 4,895 | $52.34 | |
| 87070 | 297 | 236 | $35.58 | |
| 86140 | 2,504 | 2,252 | $26.82 | |
| 81025 | 933 | 850 | $25.02 | |
| 81003 | 2,141 | 1,936 | $19.23 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,850 | 3,516 | $15.68 |
| 80305 | 594 | 548 | $12.21 | |
| 87807 | 28 | 24 | $11.79 | |
| 85610 | 830 | 696 | $9.09 | |
| 87088 | 366 | 323 | $8.81 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,950 | 1,627 | $8.78 |
| 84443 | Thyroid stimulating hormone (TSH) | 1,332 | 1,192 | $8.37 |
| 85730 | 278 | 237 | $7.40 | |
| 83880 | 222 | 204 | $6.57 | |
| 88304 | 100 | 92 | $3.01 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,099 | 1,549 | $1.93 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 861 | 687 | $1.86 |
| 85027 | 22 | 15 | $0.96 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,310 | 1,832 | $0.55 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,078 | 1,767 | $0.36 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 968 | 835 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 583 | 542 | $0.00 |
| C1769 | Guide wire | 14 | 12 | $0.00 |
| 83735 | 746 | 631 | $0.00 | |
| 82077 | 979 | 844 | $0.00 | |
| G0378 | Hospital observation service, per hour | 118 | 48 | $0.00 |
| 83605 | 729 | 615 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 755 | 520 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 35 | 30 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 31 | 29 | $0.00 |
| 87040 | 177 | 79 | $0.00 | |
| 87081 | 66 | 50 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 95 | 77 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 33 | 24 | $0.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 58 | 55 | $0.00 |
| 85379 | 103 | 85 | $0.00 | |
| 84703 | 62 | 54 | $0.00 | |
| 82803 | 13 | 12 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 16 | 13 | $0.00 |
| 87077 | 27 | 25 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 695 | 588 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 84 | 55 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 77 | 71 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 91 | 75 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 74 | 27 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 42 | 24 | $0.00 |
| Q9960 | High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml | 15 | 13 | $0.00 |